400042 重庆,陆军军医大学(第三军医大学)第三附属医院(野战外科研究所)泌尿外科Department of Urology, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China
Received:29 August 2018,
Published:15 February 2019
移动端阅览
Boshen LIU, Yi WANG, Linmin GUO, et al. GlcNAc inhibits MAPKs pathway in rat corpus cavernosum smooth muscle cells
Boshen LIU, Yi WANG, Linmin GUO, et al. GlcNAc inhibits MAPKs pathway in rat corpus cavernosum smooth muscle cells
目的
2
探讨β-N-乙酰氨基葡萄糖(β-N-acetylglucosamine
GlcNAc)对大鼠阴茎海绵体平滑肌细胞促分裂原活化蛋白激酶(mitogen-activated protein kinases
MAPKs)通路的影响。
方法
2
分离健康成年大鼠阴茎组织,高糖培养基诱导阴茎海绵体平滑肌细胞(cavernous smooth muscle cells
CSMC)分离生长,免疫荧光、免疫组化鉴定CSMC,GlcNAc处理CSMC 12 h,分别于0、10 min、1、2、4、8、12 h收集细胞裂解液,O-(连接)N-乙酰葡糖胺转移酶(O-N-acetylglucosamine transferase
OGT)抑制剂Alloxan、O-(连接)N-乙酰葡糖胺水解酶(O-GlcNAcase
OGA)抑制剂Thiamet G及GlcNAc处理CSMC 72 h
Western blot检测蛋白总糖基化水平及MAPKs通路相关蛋白在12、72 h的磷酸化水平。
结果
2
成功分离培养大鼠CSMC,GlcNAc显著提升了CSMC细胞O-糖基化水平(
P
<
0.05)。处理细胞后12 h,GlcNAc显著抑制大鼠CSMC的ERK1/2、JNK1/2/3和p38的蛋白磷酸化水平(
P
<
0.05),处理细胞后72 h,GlcNAc显著抑制了大鼠CSMC的ERK1/2和p38蛋白磷酸化水平(
P
<
0.05),但不影响其总蛋白的表达水平(
P
>
0.05),且与Thiamet G的作用相同。另外,GlcNAc与Thiamet G能协同抑制ERK1/2、JNK1/2/3和p38的蛋白磷酸化水平(
P
<
0.05)。
结论
2
GlcNAc经O-糖基化依赖性途径抑制阴茎海绵体平滑肌细胞中MAPKs通路。
Objective
2
To investigate the effect of β-N-acetylglucosamine (GlcNAc) on the mitogen-activated protein kinases (MAPKs) pathway in rat penile cavernosum smooth muscle cells.
Methods
2
After penile tissue was collected from healthy adult rats
cavernous smooth muscle cells (CSMC) were isolated and cultured under high glucose medium. Immunofluorescence (IF) assay and immunocytochemical (ICC) assay were used to identify CSMC. Then the cells were treated with GlcNAc for 12 h
the cell lysate was collected at 0
10 min
and 1
2
4
8 and 12 h. Western blotting was employed to detect the total glycosylation level of protein and phosphorylation of MAPKs pathway-associated proteins after the cells were treated with O-N-acetylglucosamine transferase (OGT) inhibitor
Alloxan
O-GlcNAcase (OGA) inhibitor
Thiamet G
and GlcNAc.
Results
2
The rat CMSC were successfully isolated. Compared with the control cells
GlcNAc treatment significantly increased the O-glycosylation level of CSMC (
P
<
0.05). At 12 h
GlcNAc sig
nificantly inhibited ERK1/2
JNK1/2/3 and p38 (
P
<
0.05)
while at 72 h
GlcNAc significantly inhibited the phosphorylation of ERK1/2 and p38 protein in rat CSMC (
P
<
0.05)
but did not affect the levels of total proteins (
P
>
0.05)
which was the same effect of Thiamet G. In addition
GlcNAc and Thiamet G synergistically inhibited the phosphorylation levels of ERK1/2
JNK1/2/3 and p38 (
P
<
0.05).
Conclusion
2
GlcNAc inhibits MAPKs pathway in CSMC
via
O-glycosylation-dependent pathway.
SHAMLOUL R, GHANEM H. Erectile dysfunction[J]. Lancet, 2013, 381(9861): 153-165. DOI: 10.1016/S0140-6736(12)60520-0.
WINGARD C J, MOUKDAR F, PRASAD R Y, et al. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling[J]. J Sex Med, 2009, 6 (Suppl 3):269-278. DOI: 10.1111/j.1743-6109.2008.01184.x.
S-NCHEZ A, MART-NEZ P, MU-OZ M, et al. Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors[J]. Br J Pharmacol, 2014, 171(24): 5682-5695. DOI: 10.1111/bph.12870.
JANG H, BAE W J, KIM S J, et al. The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemia[J]. BMC Complement Altern Med, 2017, 17(1): 129. DOI: 10.1186/s12906-017-1588-4.
MUSICKI B, KRAMER M F, BECKER R E, et al. Inacti-vation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction[J]. Proc Natl Acad Sci U S A, 2005, 102(33): 11870-11875. DOI: 10.1073/pnas.0502488102.
SLAWSON C, COPELAND R J, HART G W. O-GlcNAc signaling: a metabolic link between diabetes and cancer?[J]. Trends Biochem Sci, 2010, 35(10): 547-555. DOI: 10.1016/j.tibs.2010.04.005.
PETI W, PAGE R. Molecular basis of MAP kinase regulation[J]. Protein Sci, 2013, 22(12): 1698-1710. DOI: 10.1002/pro.2374.
MUNIZ J J, LEITE L N, LACCHINI R, et al. Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction[J]. Can J Physiol Pharmacol, 2018, 96(3): 266-274. DOI: 10.1139/cjpp-2017-0082.
XU Y, GUAN R, LEI H, et al. Implications for differentiation of endogenous stem cells: therapeutic effect from icariside Ⅱ on a rat model of postprostatectomy erectile dysfunction[J]. Stem Cells Dev, 2015, 24(6): 747-755. DOI: 10.1089/scd.2014.0380.
MATSUI H, SOPKO N A, HANNAN J L, et al. Pathophysiology of erectile dysfunction[J]. Curr Drug Targets, 2015, 16(5): 411-419. DOI: 10.2174/13894501160515050 4114041.
SHEN Y, ZHU X, YANG X, et al. Cardamonin inhibits angiotensin Ⅱ-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation[J]. J Nat Med, 2014, 68(3): 623-629. DOI: 10.1007/s11418-014-0825-0.
LIMA V V, LOBATO N S, FILGUEIRA F P, et al. Vascular O-GlcNAcylation augments reactivity to constrictor stimuli by prolonging phosphorylated levels of the myosin light chain[J]. Braz J Med Biol Res, 2014, 47(10): 826-833. DOI: 10.1590/1414-431X20144001.
DASSANAYAKA S, JONES S P. O-GlcNAc and the cardiovascular system[J]. Pharmacol Ther, 2014, 142(1): 62-71. DOI: 10.1016/j.pharmthera.2013.11.005.
ZEIDAN Q, HART G W. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways[J]. J Cell Sci, 2010, 123(Pt 1): 13-22. DOI: 10.1242/jcs.053678.
JOHNSON G L, DOHLMAN H G, GRAVES L M. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression[J]. Curr Opin Chem Biol, 2005, 9(3): 325-331. DOI: 10.1016/j.cbpa.2005.04.004.
NIKOLAIENKO O, ERIKSEN M S, PATIL S, et al. Stimulus-evoked ERK-dependent phosphorylation of activity-regulated cytoskeleton-associated protein (Arc) regulates its neuronal subcellular localization[J]. Neuroscience, 2017, 360: 68-80. DOI: 10.1016/j.neuroscience.2017.07.026.
HOTAMISLIGIL G S, DAVIS R J. Cell signaling and stress responses[J]. Cold Spring Harb Perspect Biol, 2016, 8(10): a006072. DOI: 10.1101/cshperspect.a006072.
GOLDBERG H, WHITESIDE C, FANTUS I G. O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells[J]. Am J Physiol Endocrinol Metab, 2011, 301(4): E713-E726. DOI: 10.1152/ajpendo.00108.2011.
KNEASS Z T, MARCHASE R B. Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils[J]. J Biol Chem, 2005, 280(15): 14579-14585. DOI: 10.1074/jbc.M414066200.
NUNES K P, TOQUE H A, CALDWELL R B, et al. Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice[J]. J Sex Med, 2011, 8(12): 3335-3344. DOI: 10.1111/j.1743-6109.2011.02499.x.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
